Q1-2017 Anesthesia Services Update– Four anesthesia transactions in the first quarter of 2017 were a result of both private equity-backed platform organizations entering new markets, and strategic consolidators expanding their presence in existing markets.
Q1-2017 Behavioral Health Update– The behavioral health sector continues to be one of the most attractive spaces within healthcare for investment and consolidation. Significant reimbursement tailwinds have created a highly active mergers and acquisitions marketplace, both in terms of volume and valuations.
Q1-2017 CRO Update– The first quarter of 2017 experienced the same high valuations and favorable market fundamentals in the contract research space that were observed in 2016. Factors driving merger and acquisition activity include a robust pharma pipeline, a growing proportion of drugs under development attributed to smaller pharmaceutical companies, and an increased focus on the development of biologics and biosimilars.
Q1-2017 Healthcare IT Update– The beginning of 2017 brought a wave of consolidation activity within the Healthcare Information Technology (HIT) sector, as large strategic acquirers were eager to expand their product offerings, taking advantage of highly demanded software platforms that offer cost-saving solutions to healthcare providers.
Q1-2017 Laboratory Services Update– Variability in reimbursement has been the story of the laboratory services space throughout much of the last year. This reimbursement unpredictability has pushed the majority of private equity investors to the sidelines as they cautiously await more clarity on the future of the industry.